Mitochondrial Function in Septic Patients

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
SepsisSeptic Shock
Interventions
DRUG

Hydrocortisone

After resuscitation, hypoperfusion in the sepsis patients will be treated by fluid resuscitation and vasopressor. Some groups of patients may be not responsive to this treatment (MAP \<65 mmHg), administration of steroids to this group will be blindly randomized (treatment and control group). During resuscitation of septic shock patients with fluid resuscitation and vasopressors, some may not respond to treatment (MAP \< 65 mmHg). Patients who have shock refractory to fluid resuscitation and norepinephrine therapy for more than 0.5 mcg/kg/min will be blindly randomized to receive steroid (treatment group) or placebo (control group). Blood samples will be obtained to determine mitochondrial functioning before, at day 1 and day 7 after administration of study medications in both groups.

Trial Locations (1)

50200

Emergency Department, Faculty of Medicine, Chaing Mai University, Chiang Mai

All Listed Sponsors
lead

Chiang Mai University

OTHER

NCT03748537 - Mitochondrial Function in Septic Patients | Biotech Hunter | Biotech Hunter